NSCLC PDX Ex Vivo Imaging & Cell Line In Vitro Screens

In partnership with PhenoVista Biosciences (see our latest Press Release), we are now enrolling for a high throughput NSCLC PDX Ex Vivo Imaging Screen and In Vitro Cell Line Screen. 

NSCLC PDX Ex Vivo Imaging & Cell Line In Vitro Screens
NSCLC PDX Ex Vivo Imaging & Cell Line In Vitro Screens

ENROLLMENT OPEN NOW THROUGH January 24th

  • Choose from 30 low passage PDX models and/or 45 human cell lines.
  • PDX models are well characterized within Vivo SOC & patient responses clinical annotation, and NGS.
  • FREE SOC ex vivo/in vitro response will be provided for each model.
  • PDX Ex Vivo Screen readouts are Cell Viability normalized to DMSO, with drug IC50s.
  • In Vitro Cell Line readout is proliferation/cell viability by Cell Titer-Glo.
  • Enrollment is open until January 24th, 2020. 

Available on first-come, first-serve basis

Contact us today to enroll in this screen.